Total Funding
18
Total FundingGrant raised
Growth Score in past quarter
pts
Heat Score 18 in past quarter
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Commence Bio is a therapeutics company developing methods to improve the anti-inflammatory properties of stem cells.
Tom Isett: Co-Founder & CEOPast Role: iBio, Executive Co-Chairman- Ruth Waterman: Co-Founder & CMO
About the Company
Commence Bio is a therapeutics company developing methods to improve the anti-inflammatory properties of stem cells. Commence aims to apply these methods in various inflammation-related disorders, including rheumatoid arthritis, by creating uniform cellular therapeutics with predictable behaviors.
Women Founded